Clinical trials: Type 2 DM
Type 2 Diabetes, Diabetic Cardiomyopathy
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a…
- Conditions
- Type 2 Diabetes, Diabetic Cardiomyopathy, Heart Failure, Cardiometabolic Diseases
- Trial name
- STRONG-DM (NCT06593327)
- Testing
- Intensive Prevention Strategy
- Where
- 3 sites in United States
- Volunteers
- 300 people
- Sponsor
- University of Texas Southwestern Medical Center
Type 2 Diabetes Mellitus, Liver Dysfunction
Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)
This clinical trial is designed to assess the effect of hepatic impairment on the pharmacokinetic and pharmacodynamic of glufast tablets 10 mg.
- Trial name
- NCT04349696
- Testing
- Mitiglinide
- Where
- 2 sites in Taiwan
- Volunteers
- 16 people
- Sponsor
- Orient Europharma Co., Ltd.
Diabetes Mellitus, Type 2
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
The study is a randomized control trial involving 100 participants (formerly incarcerated Black men with poorly controlled diabetes) to examine the effect of a tailored nurse case manager on glycemic control and other clinical…
- Trial name
- MANAGe-DM (NCT06031428)
- Testing
- MANAGe-DM - novel nurse case management, Monthly Educational Mailing
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Medical College of Wisconsin
Diabetes Mellitus, Type II
The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.
- Trial name
- NCT00131287
- Testing
- Extract of Agaricus blazei Murill
- Where
- Taiwan
- Volunteers
- 108 people, healthy volunteers welcome
- Sponsor
- ECbiotech Taiwan
Diabetes Mellitus, Insulin Resistance
Effect of HIIT Vs Moderate Intensity Aerobic Exercise on Insulin Resistance in Type 2 DM
Comparing between the efficacy of high intensity interval training and moderate intensity aerobic exercises on insulin resistance in type 2 Diabetes Mellitus.
- Trial name
- NCT05902546
- Testing
- High intensity interval training, moderate intensity aerobic exercise
- Where
- 4 sites in Egypt
- Volunteers
- 80 people
- Sponsor
- Badr University
Diabetes Mellitus, Type 2
Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
This superiority of central pressure versus peripheral measures to predict cardiovascular events has also been reported in general population or in elder people
- Trial name
- NCT02919059
- Testing
- Dapagliflozin 10 mg, Glimepiride 4 mg
- Where
- Spain
- Volunteers
- 159 people
- Sponsor
- IInstituto Gallego de Medicina Vascular
Diabetes (DM), Vitamin D Deficiency
Comparison of Different Doses of Vitamin D Supplementation on Glycated Haemoglobin and Blood Glucose Parameters With Type II Diabetes Mellitus Having Vitamin d Deficiency
COMPARISON OF DIFFERENT DOSES OF VITAMIN D SUPPLEMENTATION ON GLYCATED HEMOGLOBIN (HbA1c) and BLOOD GLUCOSE PARAMETRS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS HAVING VITAMIN D DEFICIENCY"
- Trial name
- NCT07321223
- Testing
- Vitamin D
- Where
- Pakistan
- Volunteers
- 108 people
- Sponsor
- University of Lahore
Type 2 Diabetes
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
The purpose of this investigation is to describe general safety profile of type II Diabetes Mellitus (DM) Japanese patients under exenatide therapy in real world medical practices
- Trial name
- NCT01817569
- Where
- 46 sites in Japan
- Volunteers
- 2,948 people
- Sponsor
- AstraZeneca
Psoriatic Arthritis, Osteoarthitis
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
CARTIZ is a prospective observational clinical registry of adults in Mexico receiving tirzepatide (a dual GLP-1/GIP receptor agonist) under an independent clinical indication - typically type 2 diabetes, insulin resistance…
- Conditions
- Psoriatic Arthritis, Osteoarthitis, Knee, Diabetes (DM)
- Trial name
- CARTIZ (NCT07567378)
- Testing
- Tirzepatide
- Where
- Mexico
- Volunteers
- 30 people
- Sponsor
- JULIO GRANADOS MONTIEL